Journal
BLOOD
Volume 133, Issue 7, Pages 629-630Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-12-892778
Keywords
-
Categories
Ask authors/readers for more resources
In this issue of Blood, Zhao et al explored the role of low doses of the histone deacetylase inhibitor (HDACi) chidamide in restoring immune tolerance in patients with immune thrombocytopenia (ITP).(1)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
